We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bile Enables Norovirus to Grow in Laboratory Cell Cultures

By LabMedica International staff writers
Posted on 07 Sep 2016
Bile proved to be the key to the first successful growth of norovirus in laboratory cell cultures.

Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. More...
Human norovirus will not infect any of the species typically used in biomedical research, such as mice, rats, or rabbits nor will it grow in human cell cultures.

After the failure of many previous attempts to cultivate norovirus in cell cultures, investigators at Baylor College of Medicine (Houston, TX, USA) turned to a recently developed human intestinal epithelial cell culture system that included enterocytes. These novel, multi-cellular human cultures, called enteroids, were made from adult intestinal stem cells from patient tissues.

The investigators reported in the August 25, 2016, online edition of the journal Science that novel cell culture system not withstanding, the method was not impressively successful until they added bile, a critical factor of the intestinal milieu. With the addition of bile, the culture system recapitulated the human intestinal epithelium, permitting human host-pathogen studies of previously non-cultivatable pathogens, and allowed the assessment of methods to prevent and treat human NoV infections.

"When we added bile to the cultures, norovirus strains that did not grow before now grew in large numbers," said senior author Dr. Mary Estes, professor of human and molecular virology and microbiology at Baylor College of Medicine. "People have been trying to grow norovirus in the lab for a very long time. We tried for the last 20 years. Despite all the attempts and the success of growing other viruses, it remained a mystery why noroviruses were so hard to work with. We were able to grow norovirus in cultures that mimic the intestinal environment, where the virus naturally grows, by adding bile to the cultures. Bile is critical for several important bacterial pathogens, but this is the first time it has been shown that bile is important for the replication of human intestinal viruses."

Related Links:
Baylor College of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
All-in-One Molecular System
AIO M160
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.